MedTrace Logo

Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease

NCT03038334 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-01-31

No results posted yet for this study

Summary

This study is to examine the possible effect of supplementing Magnesium sulfate on patients with Alzheimer Disease (AD) in controlling or reducing the amount of amyloid present in the brain, and increasing cognitive ability in individuals that have amyloid deposits.

Conditions

  • Alzheimer Disease

Interventions

DIETARY_SUPPLEMENT

Magnesium sulfate

Transdermal application of Magnesium sulfate 250mg every four hours per day for 90 days.

Sponsors & Collaborators

  • Metabolic Therapy Inc.

    lead OTHER

Principal Investigators

  • Andreana Haley, PhD · University of Texas - Austin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-20
Primary Completion
2019-08-20
Completion
2019-10-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038334 on ClinicalTrials.gov